Ausgabe 1/2013
Inhalt (9 Artikel)
Editorial
Cost-Effectiveness Assessment of Orphan Drugs
Steven Simoens, Eline Picavet, Marc Dooms, David Cassiman, Thomas Morel
Open Access
Review Article
Pipeline™ Embolization Device for the Treatment of Complex Intracranial Aneurysms
Kathleen Withers, Grace Carolan-Rees, Megan Dale
Systematic Review
A Systematic Review of Economic Evaluations in Second and Later Lines of Therapy for the Treatment of Non-Small Cell Lung Cancer
Anne Jäkel, Melanie Plested, Kuntal Dharamshi, Rakhee Modha, Sarah Bridge, Adam Johns
Original Research Article
Lessons from Game Theory about Healthcare System Price Inflation
Mark D. Agee, Zane Gates
Original Research Article
Assessing the Cost Utility of Response-Guided Therapy in Patients with Chronic Hepatitis C Genotype 1 in the UK Using the MONARCH Model
Phil McEwan, Ray Kim, Yong Yuan
Original Research Article
Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
Elamin H. Elbasha, Jagpreet Chhatwal, Shannon A. Ferrante, Antoine C. El Khoury, Pedro A. Laires
Correspondence
A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing
Brian Godman, Lars L. Gustafsson
Correspondence
Authors’ Reply to Godman and Gustafsson: “A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing”
Ulf Persson, Johanna Svensson, Billie Pettersson